Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/
Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com
Life Sciences Financings and Commentary #9 — May 23, 2020 — May 29, 2020
Financings
Number of deals: 20 & Total capital invested: $1.05B
- AbCellera raised $105M led by OrbiMed and DCVC Bio to continue to scale up their antibody discovery platform and build their internal pipeline of medicines.
- Apeel Sciences raised $250M led by GIC to commercialize their plant-based coverings to extend the shelf-life of specialty crops.
- Ascus Biosciences raised $46M led by Temasek to commercialize feedstock focused on animal microbiome health.
